Tag: Pharma
Doceree recognized by OpenAI for crossing 10 billion tokens
Through its proprietary AI infrastructure, Doceree empowers pharmaceutical and life-sciences organizations to reach and engage HCPs more effectively
India’s healthcare & pharma deals surge in Q3 2025 driven by...
The surge was driven by seven high value deals worth USD 2.6 billion, reflecting renewed investor confidence in scale and consolidation plays across pharma, biotech, and hospital segments
Sanofi India Board appoints Deepak Arora as its new Managing Director
Deepak brings over 30 years of experience in the Pharmaceutical & Healthcare industry across North America, Europe, Middle East and Africa
IGMPI strengthens leadership in specialized training for pharma a allied industries
With a sharp focus on Good Manufacturing Practices (GMP), Quality Assurance, and Regulatory Affairs, the institute equips learners to navigate complex compliance environments and uphold international standards of safety and quality.
Hikal inaugurates HPAPI Lab at its Pune Innovation Centre
The facility has been designed with a range of advanced features to ensure both safety and efficiency
Lupin unveils strategic partnership program to expand reach of its long-acting...
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
AstraZeneca secures CDSCO approval for expanded use of Trastuzumab Deruxtecan in...
This marks the first and only antibody drug conjugate (ADC) in India with a tumour-agnostic indication, representing a significant advancement in precision oncology
Eli Lilly expands operations in India, to invest $1 Billion for...
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda
Dr Sharvil Patel named IPA President; Glenn Saldanha takes over as...
Dr Sharvil Patel, Managing Director, Zydus Lifesciences appointed as President, IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark, appointed as Vice President, IPA
Starpharma and Genentech partner to advance next-generation cancer therapies
Starpharma’s DEP® platform technology offers significant benefits in drug development, including improved solubility, increased efficacy, pharmacokinetic control, and improved toxicity profiles






























































